Recensioni verificate Soddisfatta del servizio.
Personale disponibile e gentile. Lo consiglio a tutti ...
Cliente Sorgente Genetica
logomysorgente

02  4948  5291

  • Cos'è AURORA

    Aurora è il test di screening prenatale di ultima generazione 
    sicuro, affidabile,
    veloce e precoce

  • Sicuro

    Grazie a un semplice prelievo di sangue materno
    eviti il rischio di aborto di tecniche invasive come amniocentesi o villocentesi

  • Affidabile

    Oltre il 99,9% di affidabilità nel rilevare
    la trisomia 21, responsabile
    della Sindrome di Down

  • Precoce e veloce

    icona svegliaIndividuare precocemente la presenza di anomalie cromosomiche è fondamentale:
    puoi effettuare Aurora dalla 10ª settimana

    icona documentoIl test è veloce: risultati in 7-10 giorni lavorativi con la percentuale di test da ripetere più bassa del mercato: 0,1%

  • La serenità della mamma
    in 3 semplici passi

    icotelefona

    Prenota il test

    icoesami

    Fai un prelievo di sangue

    icoginecologo

    Leggi i risultati

  • Test diagnosi prenatale non invasivo
  • 151126 banner Aurora mobile 01
  • 151126 banner Aurora mobile 02
  • 151126 banner Aurora mobile 03
  • slide mobile03
cover cartoon
cover venturetti

Ultime notizie dal mondo della genetica


Chronic intestinal atrial dysrhythmia syndrome

Chronic intestinal atrial dysrhythmia syndrome (CAID) is a rare disease discovered only in 2014 and also called "Viking syndrome". It is caused by a rare genetic mutation and affects both the heart and the intestine. The contractions of the two organs are in fact linked to a single gene, which would be the one affected by the disease.

A team of Canadian researchers has developed a diagnostic test for the disease, based primarily on clinical analyzes. In fact, those who suffer suffer heart and intestinal problems, both of a rather serious entity. Heart problems include slow heartbeat, which forces 50% of patients to implant a pacemaker. Instead, digestive problems manifest themselves with chronic intestinal obstructions, which can only be dealt with by intravenous feeding.

For the time being, no less invasive treatments are available. The disease is indeed rather young. Scientists discovered it by analyzing the DNA of some Canadian patients of French and Scandinavian origins. All patients showed both cardiac and gastrointestinal symptoms, related to a mutation of the SGOL1 gene. Studies in guinea pigs with similar symptoms have confirmed the role of the gene in the development of the disease.

According to the researchers, the mutation of SGOL1 is likely to reduce the protection of certain cells in the intestine and heart. When in health, the gene could in fact have the task of maintaining the rhythm of the heart throughout its life. When the mutation is present, the cells begin to multiply uncontrollably and grow older.

Source: umontreal.ca

Link social

Link social